These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 399164)

  • 1. [Determination of plasmatic C-peptide and its clinical uses].
    Cautela G; Barbero PL; Gamba S; Regis G; Bruni B
    Ann Osp Maria Vittoria Torino; 1978; 21(7-12):203-37. PubMed ID: 399164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 3. [Usefulness of the determination of C-peptide and proinsulin in the extrahepatic serum for the evaluation of the function of the B cells of the islands of Langerhans].
    Czyzyk A
    Pol Arch Med Wewn; 1983; 69(4-5):249-57. PubMed ID: 6356053
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pancreatic beta cell function and the C-peptide content in the blood serum in thyrotoxicosis].
    Pavliuk PM; Slavnov VN; Epshteĭn EV
    Klin Med (Mosk); 1982 Apr; 60(4):51-4. PubMed ID: 7047893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood serum C-peptide level after arginine stimulation in the early and later stage of insulin-dependent diabetes].
    Miedzińska-Szadkowska E; Lawecki J; Symonides-Lawecka A
    Pol Arch Med Wewn; 1980 Nov; 64(5):421-9. PubMed ID: 7012801
    [No Abstract]   [Full Text] [Related]  

  • 6. [The clinical value of C-peptide assay (author's transl)].
    Vialettes B; Vague P
    Diabete Metab; 1980 Sep; 6(3):225-9. PubMed ID: 7002655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

  • 8. C-peptide measurement: methods and clinical utility.
    Bonser AM; Garcia-Webb P
    Crit Rev Clin Lab Sci; 1984; 19(4):297-352. PubMed ID: 6373142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in beta-cell function in functional ovarian hyperandrogenism.
    O'Meara NM; Blackman JD; Ehrmann DA; Barnes RB; Jaspan JB; Rosenfield RL; Polonsky KS
    J Clin Endocrinol Metab; 1993 May; 76(5):1241-7. PubMed ID: 8496316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of insulin secretory capacity in diabetes mellitus.
    Horwitz DL; Rubenstein AH
    Hum Pathol; 1979 May; 10(3):257-66. PubMed ID: 381153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.
    Rubenstein AH; Kuzuya H; Horwitz DL
    Arch Intern Med; 1977 May; 137(5):625-32. PubMed ID: 193451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How is the insulin content regulated in nondiabetic hyperinsulinaemic, insulin resistant states? Study of spontaneously hypertensive rats.
    Leahy JL; Chen C; Rhodes CJ
    Diabetologia; 1998 Jul; 41(7):855-9. PubMed ID: 9686930
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.
    Garcia-Webb P; Bonser A; Welborn TA
    Diabetologia; 1982 Apr; 22(4):296. PubMed ID: 7047275
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of self-induced hyperinsulinism in an insulin-dependent diabetic patient by radioimmunoassay of free C-peptide.
    Meistas MT; Kumar MS; Schumacher OP
    Clin Chem; 1981 Jan; 27(1):184-6. PubMed ID: 7004666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
    Beischer W
    Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating C peptide: measurement and clinical application.
    Ashby JP; Frier BM
    Ann Clin Biochem; 1981 May; 18(Pt 3):125-30. PubMed ID: 7025731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma C-peptide assay and the clinical significance].
    Kaku K; Nagasaka Y; Kaneko T
    Nihon Rinsho; 1990 Feb; 48 Suppl():48-50. PubMed ID: 2192142
    [No Abstract]   [Full Text] [Related]  

  • 18. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pancreatic B cell peptides: kinetic behaviour and concentrations of proinsulin, insulin and C-peptide in plasma and urine, problems of assay methods, clinical significance and literature review (author's transl)].
    Gerbitz KD
    J Clin Chem Clin Biochem; 1980 Jun; 18(6):313-26. PubMed ID: 7000969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of plasma C-peptide analysis and the analytical method in the diagnosis of diabetes related diseases].
    Matsuda A
    Nihon Rinsho; 1990 Dec; 48 Suppl():284-92. PubMed ID: 2086901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.